This is not about the brand names, it is about the two molecules behind them: semaglutide and tirzepatide. Head-to-head, tirzepatide takes off more weight and is tolerated at least as well. Here is what the evidence shows, and how we choose between them for a given patient.
Reviewed by Dr. David Oliak, board-certified surgeon (20+ years in weight-loss surgery)
Updated August 2026
The comparison people search for is "Ozempic vs. Zepbound," but those are two brand names for two different molecules, and one of them is not even the weight-loss version.
Semaglutide is sold as Ozempic and Rybelsus for type 2 diabetes and as Wegovy for weight loss. Tirzepatide is sold as Mounjaro for diabetes and as Zepbound for weight loss.
So the honest comparison is not brand against brand; it is semaglutide against tirzepatide, the two active drugs. That is the question worth answering, and it is the one that actually changes your result.
Both drugs quiet hunger and cravings by acting on gut-hormone pathways, which, from the set-point, is exactly the leverage that matters: less pull from the band means real room to change how you eat.
The difference is how many pathways each one uses. Semaglutide acts on a single receptor, GLP-1. Tirzepatide acts on two, GLP-1 and GIP, and that second pathway is most of why it does more.
In practice, patients on tirzepatide tend to describe hunger and cravings as more thoroughly switched off, which is the effect that makes changing your eating feel achievable rather than like a daily fight.
For a long time the two drugs had only been compared indirectly, across separate studies. That changed with SURMOUNT-5, a trial that put them head-to-head in the same patients over 72 weeks.
The result was clear: tirzepatide produced about 20% average weight loss, compared with about 14% for semaglutide, each at its highest tolerated dose. The gap was wider still at the top end, where roughly twice as many people on tirzepatide lost at least a quarter of their body weight (about 32% of patients versus 16%).
And this is the part that surprises people: the more effective drug was also the better tolerated one. Fewer patients stopped tirzepatide for gastrointestinal side effects than stopped semaglutide. The common assumption that a stronger result must come with a rougher ride did not hold here.
*Head-to-head figures from the SURMOUNT-5 trial (72 weeks, highest tolerated doses).
For most patients, tirzepatide is simply the better drug, and we say that on the strength of head-to-head evidence rather than guesses from separate studies.
It takes off more weight, and it does the thing that matters most in our approach better: it quiets hunger and cravings more completely. That is what gives a person the room to change how they eat.
What settles it is tolerability. The expectation was that the stronger drug would be the harder one to stay on, and the trial showed the opposite — an unusually clean result in this field.
— Dr. David Oliak, board-certified physician and surgeon
None of this makes semaglutide a poor choice. It is an effective medication that has helped an enormous number of people, and for some patients it is the better fit.
A person who reaches their goal comfortably on semaglutide has no reason to switch. Individual tolerance varies, and some do better on one drug than the other for reasons a trial average cannot predict. Availability and cost can also point one way or the other at a given time.
The right answer is the drug that gets you a healthy result you can maintain, and for some people that is semaglutide. Our job is to match the medication to you, not to a headline.
We offer both of these medications, and both can be prescribed as brand-name product or as a compounded version through a licensed pharmacy. The active drug is the same molecule either way; the practical differences are cost and availability.
Most of our patients choose the compounded option because it costs less, but the brand-name products are available if you prefer them. We will walk through the trade-offs at your consultation and price both clearly, so the choice is yours to make with the full picture.
Whichever you choose, the medication is only part of the plan — the point of using it well is to build the habits that keep the weight off.
Choosing the drug is the easy part of this conversation, and it is where most of the internet stops.
The harder and more important part is using it well: losing the weight in a way that protects your muscle, and spending the months on the medication actually changing how you eat. That way the result lasts once you come off.
The best medication used as a shortcut still fails when it stops. The right medication used as a tool is how people succeed. Which molecule you are on matters less than that.
— Dr. David Oliak, board-certified physician and surgeon
Let's begin
The best choice depends on your history, your goals, and how you tolerate each medication, which is exactly what a consultation is for. We offer both semaglutide and tirzepatide, compounded or brand-name, and we will help you choose and use it well. Weight-loss consultations are free, often same-day. To speak with us first, call 714-671-2005.
Weight loss and your set-point
Weaning off a GLP-1 — how to do it right
Maintaining your weight after a GLP-1
Why weight-loss plateaus happen
On the evidence, yes for most people — but the fair comparison is the molecules, not the brands. Zepbound is tirzepatide; Ozempic is semaglutide (its weight-loss brand is Wegovy).
Head-to-head, tirzepatide produced more weight loss, about 20% versus 14% over 72 weeks, and was tolerated at least as well. For most patients we start with tirzepatide, though semaglutide is the right choice for some.
Semaglutide acts on one gut-hormone pathway (GLP-1); tirzepatide acts on two (GLP-1 and GIP). That second pathway is most of why tirzepatide tends to control hunger more completely and produce more weight loss.
Not in the head-to-head trial. Fewer patients stopped tirzepatide for gastrointestinal side effects than stopped semaglutide, so the more effective drug was also the better tolerated one. Side effects are still real and individual, and we manage them by starting low and titrating.
Both. We offer semaglutide and tirzepatide as brand-name product or as a compounded version from a licensed pharmacy. The molecule is the same; the difference is cost and availability. Most patients choose compounded to save money, but the choice is yours.
The one that gets you a healthy result you can maintain, which depends on your history, your goals, and how you tolerate each. For most people we start with tirzepatide; for some, semaglutide is the better fit. That is the decision a consultation is for.
